Insulin resistance: an independent risk factor for cardiovascular disease? (Englisch)
- Neue Suche nach: Balkau, B.
- Neue Suche nach: Eschwège, E.
- Neue Suche nach: Balkau, B.
- Neue Suche nach: Eschwège, E.
In:
Diabetes, Obesity and Metabolism
;
1
;
23-31
;
1999
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Insulin resistance: an independent risk factor for cardiovascular disease?
-
Beteiligte:Balkau, B. ( Autor:in ) / Eschwège, E. ( Autor:in )
-
Erschienen in:Diabetes, Obesity and Metabolism ; 1 ; 23-31
-
Verlag:
- Neue Suche nach: Blackwell Science Ltd
-
Erscheinungsdatum:01.05.1999
-
Format / Umfang:9 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
IntroductionFerrannini, E. et al. | 1999
- 1
-
Impact of the new WHO classification and diagnostic criteriaBennett, P. H. et al. | 1999
- 1
-
Insulin resistance: the fundamental trigger of type 2 diabetesGroop, L. C. et al. | 1999
- 1
-
Exciting times for pharmacological research in diabetes, obesity and metabolismDonnelly, Richard / Garber, Alan et al. | 1999
- 3
-
Nerve regeneration in diabetic neuropathyApfel, Stuart C. et al. | 1999
- 7
-
The natural history of diabetes‐related complications: the UKPDS experienceMatthews, D. R. et al. | 1999
- 8
-
The relation between insulin resistance and cardiovascular complications of the insulin resistance syndromeRett, K. et al. | 1999
- 13
-
UKPDS and beyond: into the next millenniumKrentz, Andrew J. et al. | 1999
- 14
-
The role of blood glucose‐lowering drugs in the light of the UKPDSMonnier, L. et al. | 1999
- 17
-
The association between insulin resistance and endotheliopathyTooke, J. et al. | 1999
- 23
-
Serum leptin levels are not influenced by physical training in type 2 diabetes mellitus patientsLigtenberg, P. C. / Hoekstra, J. B. L. / Frölich, M. / Meinders, A. E. / Erkelens, D. W. et al. | 1999
- 23
-
Insulin resistance: an independent risk factor for cardiovascular disease?Balkau, B. / Eschwège, E. et al. | 1999
- 24
-
Cardiovascular risk in type 2 diabetesStandl, E. et al. | 1999
- 29
-
Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea‐metformin therapy in type 2 diabetes mellitusLópez‐Alvarenga, J. C. / Aguilar‐Salinas, C. A. / Velasco‐Perez, M. L. / Arita‐Melzer, O. / Guillen, L. E. / Wong, B. / Brito, G. / Mercado, V. / Gómez‐Pérez, F. J. / Rull‐Rodrigo, J. A. et al. | 1999
- 32
-
Effects of current therapeutic interventions on insulin resistanceKobayashi, M. et al. | 1999
- 37
-
Atherothrombosis in diabetes – its evolution and managementDrouet, L. et al. | 1999
- 37
-
Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long‐Evans Tokushima Fatty Rat, a model of spontaneous NIDDMNakaya, Y. / Minami, A. / Sakamoto, S. / Niwa, Y. / Ohnaka, M. / Harada, N. / Nakamura, T. et al. | 1999
- 41
-
Promising new approachesIi, C. A. Reasner et al. | 1999
- 43
-
Clenbuterol stimulates neurotrophic support in streptozotocin‐diabetic ratsRiaz, S. S. / Tomlinson, D. R. et al. | 1999
- 49
-
Closing remarksFerrannini, E. et al. | 1999
- 53
-
Lowering of circulating insulin and leptin is closely associated following weight reduction after vertical banded gastroplasty in obese womenGuldstrand, M. / Backman, L. / Adamson, U. / Lins, P. E. / Ahrén, B. et al. | 1999
- 57
-
Smoking habits and circulating leptin in postmenopausal non‐obese womenLarsson, H. / Ahrén, B. et al. | 1999
- 61
-
News and Views| 1999
- 65
-
FDA reviews troglitazoneDonnelly, Richard et al. | 1999
- 67
-
Early intensive insulin treatment for induction of long‐term glycaemic control in type 2 diabetesGlaser, Benjamin / Cerasi, Erol et al. | 1999
- 75
-
In‐vivo and in‐vitro models of type 2 diabetes in pharmaceutical drug discoveryReed, Michael J. / Scribner, Karen A. et al. | 1999
- 97
-
A b3‐adrenergic agonist increases muscle GLUT1/GLUT4 ratio, and regulates liver glucose utilization in diabetic rats*Milagro, F. I. / Gómez‐Ambrosi, J. / Forga, L. / Martínez, J. A. et al. | 1999
- 113
-
Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albuminDesfaits, A. ‐C. / Serri, O. / Renier, G. et al. | 1999
- 127
-
The polycystic ovary syndrome: treatment with insulin sensitizing agentsIuorno, Maria J. / Nestler, John E. et al. | 1999
- 137
-
Physiological and pharmacological regulation of insulin release: insights offered through exploitation of insulin‐secreting cell linesMcClenaghan, Neville H. / Flatt, Peter R. et al. | 1999
- 151
-
Sudden death in type 1 diabetesMcNally, Paul G. / Lawrence, Ian G. / Panerai, Ronnie B. / Weston, Philip J. / Thurston, Herbert et al. | 1999
- 159
-
Non‐enzymatic glycation of lens proteins and haemoglobin–inhibition by pyruvate: an in‐vivo studyDevamanoharan, P. S. / Ali, A. H. / Varma, S. D. et al. | 1999
- 165
-
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve‐week, randomized, placebo‐controlled studyPatel, J. / Anderson, R. J. / Rappaport, E. B. et al. | 1999
- 173
-
Glucose and fatty acid metabolism in type 2 diabetes mellitus: an assessment using low‐dose insulin infusion and the hyperinsulinaemic euglycaemic clampWebber, J. / Whitelaw, D. / Smith, J. M. / Nattrass, M. et al. | 1999
- 179
-
Possible liver damage by biosynthetic human insulinShimizu, H. / Ohtani, K. ‐I. / Kudoh, T. / Tsuchiya, T. / Takahashi, H. / Sato, N. / Iriuchijima, T. / Mori, M. et al. | 1999
- 189
-
Dyslipidaemia and cardiovascular risk in diabetesCullen, Paul / Von Eckardstein, Arnold / Souris, Sotiris / Schulte, Helmut / Assmann, Gerd et al. | 1999
- 199
-
Sulphonylurea‐induced hypoglycaemia in type 2 diabetes mellitus: a reviewBurge, Mark R. / Sood, Vidushi / Sobhy, Taher A. / Rassam, Amer G. / Schade, David S. et al. | 1999
- 207
-
5‐HT2C receptor modulation and the treatment of obesityBickerdike, Mike J. / Vickers, Steven P. / Dourish, Colin T. et al. | 1999
- 215
-
Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapyStandl, E. / Baumgartl, H. J. / Füchtenbusch, M. / Stemplinger, J. et al. | 1999
- 221
-
Effect of diabetes on vitamin B6 requirement in experimental animalsOkada, M. / Shibuya, M. / Yamamoto, E. / Murakami, Y. et al. | 1999
- 227
-
Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetesHermann, L. S. / Ranstam, J. / Vaaler, S. / Melander, A. et al. | 1999
- 233
-
Long‐term oral administration of dehydroepiandrosterone has different effects on energy intake of young lean and obese male Zucker rats when compared to controls of similar metabolic body sizeRichards, R. J. / Porter, J. R. / Svec, F. et al. | 1999
- 241
-
Testosterone and leptin in a group of Chinese with and without diabetesNg, W. Y. / Lui, K. F. / Thai, A. C. et al. | 1999
- 247
-
Robert Charles TurnerGarber, Alan J. et al. | 1999
- 257
-
Is insulin resistance the principal cause of type 2 diabetes?Gerich, John E. et al. | 1999
- 265
-
Growth factors secreted by fibroblasts: role in healing diabetic foot ulcersMansbridge, Jonathan N. / Liu, Kang / Pinney, R. Emmett / Patch, Ruth / Ratcliffe, Anthony / Naughton, Gail K. et al. | 1999
- 281
-
Intracerebroventricularly administered corticotropin‐releasing factor inhibits food intake and produces anxiety‐like behaviour at very low doses in miceMomose, K. / Inui, A. / Asakawa, A. / Ueno, N. / Nakajima, M. / Fujimiya, M. / Kasuga, M. et al. | 1999
- 285
-
D‐tagatose, a novel hexose: acute effects on carbohydrate tolerance in subjects with and without type 2 diabetesDonner, T. W. / Wilber, J. F. / Ostrowski, D. et al. | 1999
- 293
-
Unfavourable impact of growth hormone (GH) discontinuation on body composition and cholesterol profiles after the completion of height growth in GH‐deficient young adultsKohno, H. / Ueyama, N. / Honda, S. et al. | 1999
- 297
-
A new hope in the nightmare of diabetic orthostatic hypotension: the midodrine–fludrocortisone associationAndreelli, F. / Plotton, I. / Thivolet, C. / Riou, J. P. et al. | 1999
- 307
-
Clinical management of diabetic nephropathyMcLaughlin, Kevin / Jardine, Alan G. et al. | 1999
- 317
-
Metabolic effects of moxonidine and other centrally acting antihypertensivesSchachter, Michael et al. | 1999
- 323
-
Insulin resistance and familial dyslipidaemiasAscaso, Juan F. / Real, José T. / Carmena, Rafael et al. | 1999
- 331
-
Effects of niacin‐bound chromium supplementation on body composition in overweight African‐American womenCrawford, V. / Scheckenbach, R. / Preuss, H. G. et al. | 1999
- 339
-
Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin‐induced diabetesSuanarunsawat, T. / Klongpanichapak, S. / Chaiyabutr, N. et al. | 1999
- 347
-
A new air displacement plethysmograph for the determination of Japanese body compositionMiyatake, N. / Nonaka, K. / Fujii, M. et al. | 1999
- 353
-
Effect of food deprivation on rat plasma estrone fatty acid estersVilà, R. / Adán, C. / Grasa, M. M. / Masanés, R. M. / Esteve, M. / Cabot, C. / Fernández‐López, J. A. / Remesar, X. / Alemany, M. et al. | 1999
- v
-
Editor’s forewordHome, Philip et al. | 1999